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ABSTRACT 
Lead is a heavy metal that has been known for its adverse effects on many body organs and 
systems and thus their functions. In this study, the toxic effect of lead on blood was 
investigated, and ethanolic extract of Phoenix dactylifera L. (EPD) (a well known nutritious, 
antioxidant, and medicinal fruit) was administered orally to prevent lead’s toxicity.  Forty adult 
male Wister rats, randomly divided into four groups (n = 10), were used for this study Group B 
and Group D were given 200 g of EPD/Kg Body Weight/Day (orally) and 1% sodium acetate 
and Lead acetate respectively, while group A (control) and  group C were given sodium acetate 
and lead acetate respectively. All treatments were for eight weeks. The animals were weighed 
and then sacrificed twenty-four hours after the last treatment. Hematocrit, red and white blood 
cell counts (RBC and WBC), differential count, hemoglobin concentration and other 
hematological parameters were determined. The data obtained were compared using t-test. The 
results showed that lead caused a significant decrease in hematocrit, RBC, WBC, hemoglobin 
concentration, mean corpuscular hemoglobin, mean corpuscular hemoglobin concentration, 
and lymphocyte and monocyte count; and significant increase in neutrophil count. These were, 
however, prevented in the EPD treated groups.  It is therefore concluded that oral admistration 
of EPD promotes blood’s health and annuls lead induced hematotoxicity. 
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INTRODUCTION  
Lead is one of the first metals to be smelted and used (Aicheson, 1960).  It probably was first mined in Turkey 
around 3500 BC (Alan, 2010).  Its density, workability and corrosion resistance were among the metals attractions 
(Flora, 2008). Reasonably, lead poisoning [plumbism or painter’s Colic (Kosnett, 2006)] is one of the oldest known 
environmental hazards (Flora, 2008). Also, no level of lead in the body below which no harm can occur has been 
discovered (Merrill et al., 2007). Worst still, the levels of lead found in most people today are of magnitudes greater 
than those of pre-industrial times (Merrill et al., 2007; Patrick 2006). In fact, humans get exposed to lead through 
various media: air, water, soil, food and consumer products (Gärtner, 1997; Gidlow, 2004; Thompson, 2006).  
 
Lead interferes with a variety of body processes and is toxic to the body systems including the cardiovascular, 
reproductive, haematopoietic, gastrointestinal, and nervous systems (Kosnett, 2006), renal functions (Patocka and 
Cerný, 2003), release of glutamate and learning (Xu et al., 2006). It affects the hematological system [even at 
concentrations below 10µg/dl (ATSDR, 2005)] by inhibiting the activities of several enzymes [particularly Amino 
Levulinic Acid Dehydratase (ALAD)] involved in heme biosynthesis and shortening of erythrocyte life span (Sakai 
et al., 1999) as well as inducing inappropriate production of erythropoietin leading to inadequate maturation of red 
cell progenitors and affecting the introduction of Fe2+ into protoporphyrin IX (Taketani et al., 2001). Even though 
manifestations of Pb poisoning in humans are non-specific, they are always accompanied by oxidation (Hande et al., 
2004). 
On the other hand date palm (Phoenix dactylifera) fruits, an important component of diet in the arid and semiarid 
regions of the world (Biglari et al., 2008), are widely used in traditional medicine for the treatment of various  
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disorders e.g. memory disturbances, fever, inflammation, paralysis, loss of consciousness, nervous disorders 
(Nadkarni, 2006), and as a detersive and astringent in intestinal troubles. It is also used in the treatment for sore 
throat, colds, bronchial asthma, to relieve fever, cystitis, gonorrhea, edema, liver and abdominal troubles and to 
counteract alcohol intoxication (Barh and Mazumdar, 2008). It possesses anticancer, antimutagenic, 
antihyperlipidemic, nephroprotective, and in vivo antiviral activities, and the ability to increase the concentration of 
testosterone, follicle stimulating hormone and luteininzing hormone (Bahmanpour et al., 2006). Many researchers 
have also documented the antioxidant property of Phoenix dactylifera (Mohamed and Al-Okbi, 2004; Allaith and 
Abdul, 2005; Al-Qarawi et al., 2008). 
Since humans are inseparable from their environment and almost entirely not free from exposure to Lead (most 
especially that lead has almost always found an important position in many industries), it is very necessary to figure 
out ways by which our body can be made to still maintain homeostasis (basis of good health) even on exposure to 
relatively high level of lead exposure. This research work, therefore, aims at knowing whether or not oral 
administration of extract of Phoenix dactylifera (EPD) prevents lead induced hemato-toxicity base on the knowledge 
that EPD has nutritious, medicinal, and antioxidant components. 
 
MATERIALS AND METHODS  
Forty adult male Wister rats [average Body Weight (BW) 186.70 ± 0.511 g] obtained from the animal house section 
of Faculty of Pharmaceutical Science, Ahmadu Bello University, Zaria, Nigeria, were used for this study. The 
animals were kept in the animal house section of Human Physiology Department, Ahmadu Bello University, Zaria, 
Nigeria, and allowed to acclimatize over a period of ten days.   
 
PLANT MATERIALS  
The fruits of Phoenix dactylifera were bought from a local market in Zaria, Kaduna State, Nigeria and authenticated 
at the Department of Biological Science, Ahmadu Bello University, Zaria, Nigeria.  
 
PREPARATION OF ETHANOLIC EXTRACT OF PHOENIX DACTYLIFERA (EPD) 
The extract of the fruits was prepared in the Department of Pharmacognosy and Drug Development, Ahmadu Bello 
University, Zaria. The extract was prepared by removing the shells of the fruit and the fruit grounded into fine 
powder. The fine powder was left to dry under shade, it was soaked in ethanol (inside a separating funnel plugged 
with cotton wool) for 24 hours. It was drained and rewashed with more ethanol. The filtrate was poured in an 
evaporating dish and placed on a water bath at 80 oC, and reduced pressure (70% atmospheric pressure) to remove 
the solvent. After all the solvent had evaporated, the extract was scrapped and stored in a dry glass container at a 
temperature of 0 – 4 oC.  Fresh solution of the extract was prepared in distilled water just before use to maintain its 
potency. 
 
ANIMAL TREATMENT 
The forty rats were randomly grouped into four (Group A, B, C and D, n = 10).  Rats in group A served as the 
control and were neither exposed to lead nor treated with EPD, but they were allowed to drink 1% sodium acetate ad 
libitum. Group B rats were allowed to drink 1% sodium acetate ad libitum and also administered 200 mg of EPD/Kg 
BW/Day. Group C and D were allowed to drink 1 % lead acetate ad libitum, while group D rats were in addition 
administered 200 mg of EPD/Kg BW/Day. All treatments were for eight weeks.  
 
ANIMAL SACRIFICE AND COLLECTION OF SAMPLES 
Twenty-four hours after the last treatment, each animal was weighed and then sacrificed by cervical dislocation and 
blood samples were collected via cardiac puncture.  Blood sample obtained from each rat was immediately 
transferred into EDTA bottle and mixed thoroughly although gently. 
  
COLLECTION OF DATA AND STATISTICAL ANALYSIS 
PCV was determined using plain capillary tubes filled with anti-coagulated blood and spinning at 5.1 x g for 20 min. 
RBC and WBC were determined using Improved Neubauer counting chamber and following the procedure 
documented by Chessbrough (1976). Field’s stain A and Field’s stain B were used for the Differential WBC.  
The control and “Test groups” were compared using t-test.  The significant level was set to P value < 0.05.  
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RESULTS  
The following results were obtained and are presented as mean ± SEM and level of significance is taken at “p value 
< 0.05” (*), “p value < 0.001” (**) and/or “p value < 0.0001” (***). 
 
WEIGHT INCREASE (G)  
Comparing their final and initial weight showed that there was significant weight gain (P-value < 0.05) is in all the 
groups over the 10 weeks of the research. There was, however, no significant difference (P-value > 0.05) in weight 
gain of NA+EPDG, LA+EPDG and Control, while weight increase in LAG had a significantly lower value when 
compared to the Control (Table 1).  
 
PACKED CELL VOLUME (PCV, %), RED BLOOD CELL COUNT (RBC, CELLS/mm3), AND WHITE BLOOD 
CELL COUNT (WBC, CELLS/mm3), HEMOGLOBIN CONCENTRATION (Hb, G/DL), MEAN 
CORPUSCULAR VOLUME (MCV, FL), MEAN CORPUSCULAR HEMOGLOBIN (MCH, PG), AND MEAN 
CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC, G/DL) 
  
The PCV and RBC of NA+EPDG and LA+EPDG were significantly (P-value < 0.05, and P-value < 0.001 
respectively) higher than that of the control. However, PCV and RBC of LAG was found to be significantly (P-value 
< 0.05) lower than that of the control. Similar trends were noted for Hb, MCH, and MCHC. While WBC and MCHC 
of LAG were found to be significantly (P-value < 0.01) lower than that of the control; but LA+EPDG and NA+EPD G 
showed no significant (P-value > 0.05) difference from the Control (Table 2). 
 
DIFFERENTIAL COUNT  
Differential count showed that LA
 G, unlike NA+EPD G and LA+EPD G, has significantly (P-value < 0.05) lower 
percentage of Lymphocyte and Monocyte, but significantly (P-value < 0.05) higher percentage of Neutrophil. 
Percentages of Eosinophil and Basophil of NA+EPD and LA+EPD were however not different from that of the 
Control (Table 3). 
 
DISCUSSION 
The results of this study show that chronic exposure to Pb significantly (P-value < 0.05) reduces weight gain (Table 
1), this is in support of the findings of Suzan and Ghayasuddin (1999) and can be linked to the less efficient 
metabolic processes associated with Pb toxicity (Struzyńska et al., 1997), that is the anti-metabolic effect of Lead 
(Biswas and Ghosh, 2004). Administration of 200 mg of EPD/Kg BW/Day, however, annuls this Pb’s adverse effect 
on weight gain; it in fact had a significant (P-value < 0.05) enhancing effect on the final BW of group B and group 
D. This may be partly due to the fatty acid composition of EPD (National Institute for Health and Welfare, 2009); 
and mainly due to its relatively high caloric value (284 Kcal/100g) (National Institute for Health and Welfare, 2009) 
and the presence of health-protective antioxidants such as melatonin, vitamin E, and ascorbic acid in EPD (Al-
Qarawi et al., 2008) despite its relatively low protein content (6% by weight) (National Institute for Health and 
Welfare, 2009). These can similarly explain the significant (P-value < 0.05) decrease in PCV noticed in animals 
exposed to Pb (LAG) and the non significant (P-value > 0.05) decrease in PCV noticed in animals treated with EPD 
alongside Pb exposure (LA+EPDG) (Table 2). This finding that Pb reduces PCV is in support of the findings of 
Anetor et al., (2002) that some indices of erythropoietic activity such as Hb, PCV and MCHC are significantly 
decreased in workers exposed to lead. It however opposes the findings of Franson et al., (1983) that PCV is not 
affected in birds by 50 ppm of Pb in their feed; and that of Arvind and Chopra, (2003) that PCV is not affected in 
calves by 100 ppm Pb in the diet. It is, however, possible that the findings of Franson et al., (1983) and Arvind and 
Chopra, (2003) are due to the low concentration of Pb (</= 100 ppm) administered as well as the relatively short 
period of administration. 
 
The significantly (P-value < 0.05) high RBC in both NA+EPD
 G and LA+EPD G, and the significantly (P-value < 
0.05) low RBC in LA
 G compared to the control [Table 2] support the findings of James, (2007) and Salawu et al., 
(2010) that lead induces anemia especially when the exposure is chronic; and the findings of Abuharfeil et al., 
(1999) that Phoenix dactylifera promotes RBC by preventing hemolysis. These observations could be accounted for 
by the ability of Pb to interfere with energy metabolism of erythrocytes (Irena and Alina, 2003) which is one of the 
determinants of ATP concentration in erythrocytes and thus erythrocytes’ life span and RBC. This reduction in RBC 
could still be linked to the findings of Bernard et al., (1972) that acute lead (Pb) toxicity in mice produced transient  
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erythroid hypoplasia and impaired utilization of RBC 59Fe for heme synthesis. The administered EPD would 
therefore be responsible for the prevention of these lowering effects of Pb on RBC (and even the enhancement of 
RBC) in LA+EPD
 G\ probably by preventing its adverse effects on energy metabolism of erythrocytes and on the 
utilization of RBC 59Fe for heme synthesis. This becomes more evident by the significantly high (P-value < 0.05) 
RBC found in NA+EPD
 G as well (Table 2). 
 
The significantly (P-value < 0.0001) lower WBC in LA
 G, and the non-significant (P-value > 0.05) difference in the 
WBC of both NA+EPD
 G and LA+EPD G with respect to the control, further establishes that lead adversely affects 
blood and blood cells. This observation is in line with the previous publications of Nedjet et al., (2009) and Karmaus 
et al., (2005) that lead exposure is associated with a reduction in WBC. It also lends supports to scientific claims that 
lead exposure may lower body’s immunity (Grasman and Scanlon, 1995; Rabinowitz et al., 1990), more so that 
white blood cells are important part of the immune system (Karmaus et al., 2005).  Therefore, EPD must have 
somehow prevented Pb’s adverse effects on WBC, such that there was no significant difference in WBC of control 
and that of LA+EPD
 G. This could most reasonably be linked to the detoxification as well as hepatoprotective effect 
of EPD (Al-Quarawi et al., 2005). 
 
In the present study, just as documented by Sembulingam and Sembuligam (2006) that Pb (like some other 
chemicals and drugs) causes netrophilia, Pb caused a significant (P-value < 0.05) increase in Neutrophil count but 
significantly (P-value < 0.05) decreased Lymphocyte and Monocyte counts (Table 3). This is as well in support of 
the findings of Di Lorenzo et al., (2006) that mean absolute neutrophil count was significantly higher in workers 
exposed to Pb with respect to workers not exposed to Pb. In addition Neutrophils and lymphocytes were noticed to 
vary in opposite direction, which is as well in support of the documentation of Sembulingam and Sembuligam, 
(2006). However, EPD was able to prevent Pb from affecting not only WBC but differential count as well.  
Conclusively, lead causes significant decrease in hematocrit, RBC, WBC, hemoglobin concentration, mean 
corpuscular hemoglobin, mean corpuscular hemoglobin concentration, and lymphocyte and monocyte count; and 
significant increase in neutrophil count. However, oral administration of EPD prevents these lead’s adverse effects 
(in rats). It is therefore reasonable to conclud that oral admistration of EPD promotes blood’s health and annuls lead 
induced hematotoxicity. 
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Table 1:  Weight Increase (g) after the 10 Weeks of Research 
 Control NA+EPDG LAG LA+EPDG 
Weight before sacrifice (g) 216.17 ± 3.13 206.00 ± 3.61* 196.33 ± 3.95** 204.5 ± 4.74 * 
Initial weight (g) 187.33 ± 6.71 189.33 ± 7.50 187.33 ± 7.00 182.67 ± 8.01 
Weight increase (g) 28.83 ± 7.47 16.67 ± 5.96 9.00 ± 5.54* 21.83 ± 3.36 
* “P-value < 0.05” 
 
Table 2:  Packed Cell Volume (PCV, %), Red Blood Cell Count (RBC, cells/mm3), and White Blood Cell 
Count (WBC, cells/mm3), Hemoglobin concentration (Hb, g/dl), Mean Corpuscular Volume 
(MCV, fl), Mean Corpuscular Hemoglobin (MCH, pg), and Mean Corpuscular Hemoglobin 
Concentration (MCHC, g/dl) 
 Control NA+EPD
 G LA G LA+EPD G 
PCV (%) 22.200 ± 0.467 43.300 ± 0.790 ** 20.200±0.512* 33.900±1.456 * 
RBC (cells/mm3) 2.545 ± 0.0762 4.930 ± 0.070 ** 1.990±0.041* 4.610±0.208 * 
WBC (cells/mm3) 2533.33 ± 29.51 2511.67 ± 63.58  2161.67 ± 32.29 *** 2550.00 ± 113.1 
Hb (g/dl) 7.110 ± 0.076 14.270 ± 0.226** 6.540 ± 0.105* 14.710 ± 0.154 ** 
MCV (fl) 84.100 ± 0.605 86.300 ± 0.423* 83.000 ± 0.577 85.500 ± 0.582 
MCH (pg) 30.400 ± 0.542 34.100 ± 0.525* 27.100 ± 0.277* 32.00 ± 0.526* 
MCHC (g/dl) 33.300 ± 0.597 35.400 ± 0.476 30.600 ± 0.542* 33.000 ± 0.394 
* “P-value < 0.05”, ** “P-value < 0.001”, *** “P-value < 0.0001” 
 
Table 3:  Comparison of Percentage of White Blood Cells that is Neutrophil, Lymphocyte, Monocyte, 
Eosinophil and Basophil Sperm Motility across the three Groups 
 Control NA+EPD
 G LA G LA+EPD G 
Neutrophils (%) 57.83±0.872 56.00±0.894 61.83±0.872* 58.67±1.05 
Lymphocytes (%) 31.83±0.872 32.5±0.428 28.83±0.601* 30.83±0.401 
Monocyte (%) 6.33±0.667 7.33±0.558 4.667±0.422* 6.00±0.816 
Eosinophil (%) 3.167±0.543 2.833±0.307 3.5±0.428 3.50±0.224 
Basophil (%) 0.833±0.654 1.333±0.211 1.167±0.477 1.00±0.365 
* “P-value < 0.05” 
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